Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IFXY
http://www.infraxinc.com/services/site-survey/
CEO FB Post - IFXY TO REBOOT
lower s.s lotto could easily 10 bag squeeze jmo. $ifxy
$TWOH The TwoHands App fulfills $TWOH's mission and vision that focuses on organization and communication to improve family relationships despite a divorce or separation. Learn more at: http://twohandsapp.com
Nice Acquisition News out from $SING today!
Read more: http://investorsnewsmagazine.blogspot.com/2017/10/singlepoint-completes-acquisition-of.html
$TWOH Quote on OTC Markets - http://www.otcmarkets.com/stock/TWOH/quote
$MIHI bounce alert! @ .46 and already hit .90 on multiple updates this week >>
Today
NetworkNewsWire Announces Publication Highlighting Innovative Solutions in Telemedicine
https://finance.yahoo.com/news/networknewswire-announces-publication-highlighting-innovative-123000476.html
Oct 18th
Telemedicine: Reducing the Costs While Enhancing the Quality of Healthcare
https://www.prnewswire.com/news-releases/telemedicine-reducing-the-costs-while-enhancing-the-quality-of-healthcare-651425693.html
$TWOH Two Hands Corporation is a custom application development company that strives to create a complete co-parenting solution. The Company's ultimate goal is to improve the lives and families affected by divorce.
"Two Hands" is the ideal solution that will reduce the stress and worries of co-parenting. It is the product of years of searching for the ideal solution that will reduce the stress and worries of co-parenting. This application fulfills our mission and vision that focuses on organization and communication to improve family relationships despite a divorce.
$PUFXF is getting ready for operations to begin at their Grow Facility in London, Ontario
https://finance.yahoo.com/news/puf-ventures-prepares-health-canada-060100044.html
$MIHI news out! NetworkNewsWire Announces Publication Highlighting Innovative Solutions in Telemedicine
https://finance.yahoo.com/news/networknewswire-announces-publication-highlighting-innovative-123000476.html
NEW YORK, NY--(Marketwired - Oct 19, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Medical Innovation Holdings, Inc. ( OTC : MIHI ), a client of NNW that owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers.
The publication, titled, "Telemedicine: Reducing the Costs While Enhancing the Quality of Health Care," discusses companies decreasing the cost of health care services through the use of inventive telemedicine solutions.
To view the full publication, visit: https://www.networknewswire.com/telemedicine-reducing-costs-enhancing-quality-health-care/
"In its 'State of Telemedicine Report Reassessed for 2018,' health care brand strategy consulting and marketing communications firm Brandigo also reports that telemedicine is one of the fastest growing sectors in the overall health care market. The industry is on track to grow from $25.5 billion in 2015 to $57.92 billion by 2020, with a compound annual growth rate of nearly 18 percent over the next five years (http://nnw.fm/G7mxa). Educating patients on how to use this valuable resource will make a sizeable difference in how fast and how far the industry grows.
"MIHI's vastly different approach stands out from a growing field of telemedicine providers by delivering virtual telemedicine with a unique, customized software and hardware platform. Through its MSO, 3PointCare, MIHI's telemedicine approach is unlike other providers who rely on a monthly subscription with patients required to pay an encounter fee every time an on-demand physician is utilized. Under that approach, the continuum of care is broken, insurance may not be accepted, symptom-based diagnoses are the only reference, and there is no certainty the patient is being cared for by a licensed practitioner, changing the relationship from an actual medical practice to a contract service delivering virtual care."
About Medical Innovation Holdings, Inc.
Medical Innovation Holdings, Inc. owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) to bring quality medical care to all areas of need, including rural and underdeveloped areas across the country. Through its wholly owned 3Point Care subsidiary, MIHI provides personalized high-tech telemedicine encounters pairing the company's virtual health specialty doctors and traditional primary doctors that utilize next-gen virtual health technologies to connect a patient with a multi-disciplinary specialty clinical health care practice. Through its other companies and partnerships, MIHI offers Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring. The company serves a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.
For more information, visit www.MedicalInnovationHoldings.com
$GFOO
NVSOS REINSTATED CO AND GOING CURRENT!!! NO NEWS YET BUT IT WILL EXPLODE WHEN THEY DO.
https://www.barchart.com/stocks/quotes/GFOO/comparison
https://www.barchart.com/stocks/quotes/GFOO/cheat-sheet
DUE DILIGENCE
https://docs.google.com/presentation/d/1zQKVFpBZwCYsOsoQZ_iMc9RCyn3pNaXS0I6dGW_hbd4/mobilepresent?slide=id.p
SPOKE TO THE COMPANY ATTORNEY DEAN AND WAS
ADVISED IF ANYONE HAS ANY QUESTIONS TO EMAIL HIM AT INFO@DEANLAWCORP.COM or CALL THEM AT 12133376770
Per there Attorney, THE Company is currently working on becoming current on there filings and to look for new filings to be submitted.
THIS COULD BE ANOTHER DOLV!
http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=qDpp60ra6IvRyjUMURZhug%253d%253d&CorpName=GENUFOOD+ENERGY+ENZYMES+CORP.
http://nvsos.gov/SOSEntitySearch/mobile/default.html#Details
SNOA =Market-Cap $19 M /Cash balance $12.6 M /Shares Out 4.3 M / 17 FDA approvals received to date some of these products are in early launch phase plus additional Product launches expected within 6 months in USA and many more Approvals outside of USA // Annual Revenue on track to hit $16 million// Profitability expected in 2018 . This unknown ultra low float and brutally undervalued stock is a MUST HAVE for everyone who like Pharma stocks .GL
Sonoma Pharma (Nasdaq: SNOA)
Marketcap: 19.6 Million
Cash: $12.6 Million
Price: $4.55
Book Value: $4.32
Annual Revenue on track to hit $16 Million
Shares Out : 4.3 Million
Stonegate Capital Partners Updates Coverage on Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) ..October 18, 2017
http://pr.report/78EFCjq0
Fact Sheet
http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf
Driving to commercial EBITDAS breakeven, without dilution
Grow current product portfolio with all sales people
•Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
•Mondoxyne for severe acne –launched late 2015
•Ceramax for skin repair in atopic dermatitis–launched in April 2016
•SebuDerm for seborrhea dermatitis –launched in November 2016
Launch 3 New Products –our product pipeline –one every other quarter
•Launching Loyon–Fall 2017
•Ceramax in foam and gel forms –Q4 2017 & Q1 2018
Regulatory Approvals and Clearances
To date, we have obtained 17 clearances from the U.S. Food and Drug Administration, or FDA, that permit us to sell our products as medical devices for Section 510(k) of the Federal Food, Drug and Cosmetic Act in the United States.
Outside the United Sates, we sell products for dermatological and advanced tissue care with a European Conformity marking (known as Conformité Européenne or CE) covering 25 of our products, and various approvals in Central America, China, Southeast Asia, and the Middle East.
***PKTX..On IHUB PKTX message board this morning(Oct. 18th) we had a very interesting post..It was from a twitter post
Titled...The Mantra of a Biotech Investor..A Look Back on the Last 12 Months..
...It is a very eye opening account of five Bio-techs and their PPS over a timeline of a year..
...A Very Interesting comparison which could easily be where Protokinetix...Is Bound.. :+)
***On IHUB PKTX MB.. Post # 3623(Original/Twitter) or Try Post # 3625..
Oct. 18, 2017 1:36 AM ET|Includes: Champions Oncology, Inc. (CSBR), DVAX, MPME, ORGS, PKTX, ZIVO
When You're Knocked Off the Horse! Get Back On!
The Mantra of a Biotech Investor...A Look Back on the Last 12 Months
10-18-2017
I realize it's been nearly six months since my last update. My absence has not been due to lack of activity in my biotech picks. It's been 1 year since my first "Knocked Off the Horse" article. I'm taking the one-year anniversary as an opportunity to see how the last year treated my stable. The performance of a couple of my thoroughbreds had me cashing in at the ticket window and a couple of nags needed to be sent out to pasture. I'll provide a brief update on the last few months and do my best at looking forward.
First, the original 5 stocks that were written about in October 2016
CSBR, Champions Oncology - October 2016 pps - $1.67, October 2017 pps $3.31. Yep, we got a double out of this one and the opportunity for a little trading along the way. This company is starting to mature into a real biotech. If you've not done your research on this one, then do it now. It is still underfollowed and I believe still has plenty of opportunity ahead of it. CSBR is still solidly in my stable.
DVAX, Dynavax Technologies - October 2016 pps - $10.33, October 2017 pps - $22.30. That's right, another double. This stallion really took me for quite a ride. Heplisav, sd-101 and a big money raise that's what they've been up to the last 6 months, and oh I might add the stock is up 4x in the last 6 months as well. This one has a bright future ahead. He tried to buck me off last October but thankfully I was able to hang on enjoy the tried. Planning on continuing the ride into 2018.
ADHD, Alcobra - October 2016 pps - $2.47, sold on 2/2 at $1.16, October 2017 pps - $1.15 Glad to have gotten out of this one.
THLD, Threshold Pharmaceuticals - October 2016 pps - $2.47, October 2017 pps(I'm not smart enough to figure it out since the Molecular Templates acquisition) I was up a few percent but I'm out now. I just can't own a stock with the word "templates" in the name. Thanks for the ride.
PKTX, ProtoKinetix - October 2016 pps - .07, October 2017 pps - .07. Don't be fooled by the price being the same in now as it was in October 2016. This company has made far greater strides than what I had even imagined. The company began its first human trials this year and the stock got as high as $.15 on the news. I would anticipate data from these trials to begin coming out early in 2018. The trials that are currently underway are for Diabetes, that in and of itself is enough for me to own the stock, but the company put press out on 10.17.2017 and informed us that they will also be using their molecule for Kidney Ischemia, Normothermic Liver Perfusion, Retinal Cell Replacement and Monocional antibody production. This company is no one trick pony! The stock doesn't get the attention it should, this is in large part due to the fact it is trading at $.07, many biotech investors don't take a penny stock too seriously. A little due diligence shows that this company was resurrected from the dead by current management and now has an entirely clean cap table with no debt whatsoever and as evidenced by the recent press, they're really getting things done. It's not often I get this fired up about a penny stock biotech, but PKTX is a penny stock in price only. The cap table and technology are deserving of a market cap far greater than what the market is currently giving it. Once they begin to release study data the market will realize this is Secretariat and not some also ran. I'm loading up on this one while she's still priced like a longshot.
ZIVO, Zivo Bioscience - Added on 2.2.17, pps on 2.2.2016 - .11, pps October 2017 - $.07 ZIVO is in my "not followed" category. These are companies with interesting stories or science but essentially no one has heard of them. I'm still hanging onto ZIVO, she's a bit boring and still doesn't trade much, but they continue to progress with their algae technology. I wouldn't bet on this to win, but she might come in with a place or show for me. She stays in the stable for now.
ORGS, Orgenesis - added 2.28.17, pps on 2.28 was $.80, pps October 2017 - $.42. I added Orgenesis to my under followed category but the jockey continues to change, I'm actually not even sure it has a jockey. I've now added ORGS to the glue factory category. I'll take another look again if they ever get management figured out. Taking all proceeds and adding to PKTX.
ACXA, Accurexa, added to the not followed list on 4.02.2017 when the stock was at $.18. Last trade on 10.17.2017 was just over .09. I'm sending this one out to pasture as well. The science is intriguing but the cap table is a mess and the ownership/management structure is a convoluted mess. Proceeds from this go to PKTX as well.
....Disclosure: I am/we are long ZIVO, PKTX, DVAX, CSBR.
$MIHI .69 falling on huge news out! >>
Telemedicine: Reducing the Costs While Enhancing the Quality of Healthcare
https://www.prnewswire.com/news-releases/telemedicine-reducing-the-costs-while-enhancing-the-quality-of-healthcare-651425693.html
NEW YORK, October 18, 2017 /PRNewswire/ --
Nature's impact on healthcare can't be overstated in light of the nation's recent spate of natural disasters that have battered Texas, Louisiana, Florida and California. Residents in these states face incredible challenges when it comes to finding proper medical care, but it's not just during times of natural disaster that people need access to quality healthcare. It is also an everyday problem for millions of Americans living in rural regions designated as "medically underserved." Telemedicine offers solutions that can make a significant difference to location-based healthcare challenges by offering access to services regardless of an individual's location. Several companies offering telemedicine solutions are Medical Innovation Holdings, Inc. (OTC: MIHI) (MIHI Profile), Teladoc, Inc. (NYSE: TDOC), Cigna Corporation (NYSE: CI), Anthem, Inc. (NYSE: ANTM) and UnitedHealth Group, Inc. (NYSE: UNH).
In its 2017 Leadership survey, The American Telemedicine Association (ATA) reported an increasing demand for telehealthcare services, with 98 percent of telemedicine executives stating that organizations offering telemedicine have a competitive advantage over those that do not (http://nnw.fm/29NLg ). The report, based on 171 respondents in executive leadership positions representing telehealth service providers, healthcare practices, and hospital systems, offers an overwhelmingly optimistic view for the future of the telehealth industry. This positive attitude is based not on wishful thinking, but on the undeniable fact that patient-centered healthcare and electronic health record (EHR) interoperability is becoming a critical piece of the nation's health information network.
In its "State of Telemedicine Report Reassessed for 2018 ," healthcare brand strategy consulting and marketing communications firm Brandigo also reports that telemedicine is one of the fastest growing sectors in the overall healthcare market. The industry is on track to grow from $25.5 billion in 2015 to $57.92 billion by 2020, with a compound annual growth rate of nearly 18 percent over the next five years (http://nnw.fm/G7mxa). Educating patients on how to use this valuable resource will make a sizeable difference in how fast and how far the industry grows.
Colorado-based Medical Innovation Holdings (OTC: MIHI) is quickly becoming a vital part of this expanding virtual healthcare industry. MIHI owns and operates strategically aligned healthcare service companies focused on the delivery of clinical virtual medicine, also known as telehealth and telemedicine. Through its wholly owned subsidiaries, MIHI provides personalized high-tech, high-touch telemedicine encounters pairing its virtual health specialty doctors with primary care physicians. This synergy of forces includes the use of nextgen virtual health technologies that connect a patient with a multi-disciplinary specialty clinical healthcare practice (http://nnw.fm/c1Gyd).
MIHI also provides ancillary products and services that improve health, provide product choices, and increase engagement and revenue. These services include lab, nutraceuticals, prescriptive medicine, and remote diagnostic support. The company's recent launch of Telemedicos USA, a Spanish-language healthcare platform positioned to address the 58 million Hispanics living in the United States, is addressing another immediate, glaring healthcare need (http://nnw.fm/Aap7E), and demonstrates the company's ability to recognize a market opportunity and execute a plan to meet industry demand.
"This was a natural evolution for us. We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community," MIHI CEO Jake Sanchez stated in the news release. "We have a Mexican-American CEO, two of our three board members are Hispanic (Mexican American and Colombian), and some of our largest shareholders are Panamanian, Puerto Rican and Cuban. We know the Hispanic community, and the community knows us."
Telemedicos USA will use primary care, on-demand telemedicine services to provide unparalleled access to healthcare, including pharmaceuticals, alternative medicines and patient portals to create a cloud-based electronic medical record that effectively "travels with the patient."
MIHI's vastly different approach stands out from a growing field of telemedicine providers by delivering virtual telemedicine with a unique, customized software and hardware platform. Through its MSO, 3PointCare, MIHI's telemedicine approach is unlike other providers who rely on a monthly subscription with patients required to pay an encounter fee every time an on-demand physician is utilized. Under that approach, the continuum of care is broken, insurance may not be accepted, symptom-based diagnoses are the only reference, and there is no certainty the patient is being cared for by a licensed practitioner, changing the relationship from an actual medical practice to a contract service delivering virtual care.
Under MIHI's visionary approach and through its 3PointCare, doctors are deployed through an established medical practice without requiring a subscription fee. The company works with anyone covered by insurance, including Medicare and Medicaid, in a partnership with the patient's primary care physician. Deductibles can be captured, which allows patients to take advantage of medical tax deductions, since MIHI utilizes an integrated software application that enables the processing of insurance claims so that doctors are paid for their services.
The company's TeleLifeMd, a multi-disciplinary specialty healthcare practice with strong experience in telemedicine, primarily delivers patient medical care, while 3PointCare has a unique and exclusive relationship with the service. It is a well-rounded, reliable method of providing all levels of service needed by a medical practice seeking telemedicine options. From providing telemedicine hardware and software products and support, to processing claims, paying all invoices and payroll incurred by TeleLifeMd, as well as any other service required to operate the practice, the continuum of care remains unbroken providing a critical connection between patients, medical providers, and healthcare specialists.
Another telehealth company opening its virtual doors to patients is Teladoc (NYSE: TDOC). The company's network of more than 3,100 members delivers on-demand healthcare to millions of patients via mobile devices, the Internet, video and phone. Teladoc members recently announced free consultations to victims of Hurricane Harvey, whether they were members of the service or not. The company said in a press release it would provide non-emergency medical care to those people displaced from their regular doctors and routines (http://nnw.fm/272lJ).
The idea that large healthcare organizations can offer real-time help through telemedicine is taking shape in other ways. Cigna (NYSE: CI), one of the nation's largest managed-care organizations with a little over 14 million medical members, recently reached out to victims of the mass shooting in Las Vegas, offering online support services for anyone affected by the tragedy in any way (https://www.cigna.com). Cigna typically provides health insurance services to individuals mainly through the group or employer market. Cigna is a leader in the commercial self-funded fee market and participates in other insurance and retirement businesses.
Prior to the approach of Hurricane Irma in September, Anthem (NYSE: ANTM) announced that it would also offer free online medical and psychological visits to anyone impacted by the natural disaster (http://nnw.fm/jikF8). With approximately 40 million members, Anthem is one of the largest managed-care organizations in the United States. The company provides health insurance services to more than 74 million people through its affiliated companies.
UnitedHealth Group (NYSE: UNH) provides health insurance services to about 46 million medical members. The company provides health insurance services to its members through products for every major insurance market and delivers back-office services to providers through its Optum segment. UnitedHealth Foundation supports telemedicine services through a variety of methods, including offering grants to community initiatives developing new healthcare technologies (http://nnw.fm/3yW13).
Telemedicine continues to be one of the fastest growing sectors in the overall healthcare market, with most employers either in the planning stage of offering the service or already providing it to employees. This type of healthcare delivers new options to patients via a virtual encounter with qualified medical professionals. Telemedicine allows patients to have a continuous conversation with their primary care physicians, keeping patients more satisfied, while enabling physicians to gain a greater share of healthcare revenue. Online consultations with specialty care physicians are another important benefit of the rise in telemedicine, as are what some may call "curbside" consults for patients living in extremely rural parts of the country, according to an article in Forbes (http://nnw.fm/j7fSN).
Reducing the cost of healthcare while simultaneously increasing the quality of care and improving access to health services for millions of people will take a unique, forward-thinking vision made possible by companies that are strategically forging ahead as telemedicine pioneers. Natural disasters aren't the only time when telemedicine is destined to shine. It is in the everyday, individual approach to helping people live better, healthier lives by connecting them with medical providers who want to take a more comprehensive, continuous role in patient care.
For more information on Medical Innovation Holdings, please visit: http://medicalinnovationholdings.com/
$MIHI news out! Telemedicine: Reducing the Costs While Enhancing the Quality of Healthcare
https://www.prnewswire.com/news-releases/telemedicine-reducing-the-costs-while-enhancing-the-quality-of-healthcare-651425693.html
NEW YORK, October 18, 2017 /PRNewswire/ --
Nature's impact on healthcare can't be overstated in light of the nation's recent spate of natural disasters that have battered Texas, Louisiana, Florida and California. Residents in these states face incredible challenges when it comes to finding proper medical care, but it's not just during times of natural disaster that people need access to quality healthcare. It is also an everyday problem for millions of Americans living in rural regions designated as "medically underserved." Telemedicine offers solutions that can make a significant difference to location-based healthcare challenges by offering access to services regardless of an individual's location. Several companies offering telemedicine solutions are Medical Innovation Holdings, Inc. (OTC: MIHI) (MIHI Profile), Teladoc, Inc. (NYSE: TDOC), Cigna Corporation (NYSE: CI), Anthem, Inc. (NYSE: ANTM) and UnitedHealth Group, Inc. (NYSE: UNH).
In its 2017 Leadership survey, The American Telemedicine Association (ATA) reported an increasing demand for telehealthcare services, with 98 percent of telemedicine executives stating that organizations offering telemedicine have a competitive advantage over those that do not (http://nnw.fm/29NLg ). The report, based on 171 respondents in executive leadership positions representing telehealth service providers, healthcare practices, and hospital systems, offers an overwhelmingly optimistic view for the future of the telehealth industry. This positive attitude is based not on wishful thinking, but on the undeniable fact that patient-centered healthcare and electronic health record (EHR) interoperability is becoming a critical piece of the nation's health information network.
In its "State of Telemedicine Report Reassessed for 2018 ," healthcare brand strategy consulting and marketing communications firm Brandigo also reports that telemedicine is one of the fastest growing sectors in the overall healthcare market. The industry is on track to grow from $25.5 billion in 2015 to $57.92 billion by 2020, with a compound annual growth rate of nearly 18 percent over the next five years (http://nnw.fm/G7mxa). Educating patients on how to use this valuable resource will make a sizeable difference in how fast and how far the industry grows.
Colorado-based Medical Innovation Holdings (OTC: MIHI) is quickly becoming a vital part of this expanding virtual healthcare industry. MIHI owns and operates strategically aligned healthcare service companies focused on the delivery of clinical virtual medicine, also known as telehealth and telemedicine. Through its wholly owned subsidiaries, MIHI provides personalized high-tech, high-touch telemedicine encounters pairing its virtual health specialty doctors with primary care physicians. This synergy of forces includes the use of nextgen virtual health technologies that connect a patient with a multi-disciplinary specialty clinical healthcare practice (http://nnw.fm/c1Gyd).
MIHI also provides ancillary products and services that improve health, provide product choices, and increase engagement and revenue. These services include lab, nutraceuticals, prescriptive medicine, and remote diagnostic support. The company's recent launch of Telemedicos USA, a Spanish-language healthcare platform positioned to address the 58 million Hispanics living in the United States, is addressing another immediate, glaring healthcare need (http://nnw.fm/Aap7E), and demonstrates the company's ability to recognize a market opportunity and execute a plan to meet industry demand.
"This was a natural evolution for us. We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community," MIHI CEO Jake Sanchez stated in the news release. "We have a Mexican-American CEO, two of our three board members are Hispanic (Mexican American and Colombian), and some of our largest shareholders are Panamanian, Puerto Rican and Cuban. We know the Hispanic community, and the community knows us."
Telemedicos USA will use primary care, on-demand telemedicine services to provide unparalleled access to healthcare, including pharmaceuticals, alternative medicines and patient portals to create a cloud-based electronic medical record that effectively "travels with the patient."
MIHI's vastly different approach stands out from a growing field of telemedicine providers by delivering virtual telemedicine with a unique, customized software and hardware platform. Through its MSO, 3PointCare, MIHI's telemedicine approach is unlike other providers who rely on a monthly subscription with patients required to pay an encounter fee every time an on-demand physician is utilized. Under that approach, the continuum of care is broken, insurance may not be accepted, symptom-based diagnoses are the only reference, and there is no certainty the patient is being cared for by a licensed practitioner, changing the relationship from an actual medical practice to a contract service delivering virtual care.
Under MIHI's visionary approach and through its 3PointCare, doctors are deployed through an established medical practice without requiring a subscription fee. The company works with anyone covered by insurance, including Medicare and Medicaid, in a partnership with the patient's primary care physician. Deductibles can be captured, which allows patients to take advantage of medical tax deductions, since MIHI utilizes an integrated software application that enables the processing of insurance claims so that doctors are paid for their services.
The company's TeleLifeMd, a multi-disciplinary specialty healthcare practice with strong experience in telemedicine, primarily delivers patient medical care, while 3PointCare has a unique and exclusive relationship with the service. It is a well-rounded, reliable method of providing all levels of service needed by a medical practice seeking telemedicine options. From providing telemedicine hardware and software products and support, to processing claims, paying all invoices and payroll incurred by TeleLifeMd, as well as any other service required to operate the practice, the continuum of care remains unbroken providing a critical connection between patients, medical providers, and healthcare specialists.
Another telehealth company opening its virtual doors to patients is Teladoc (NYSE: TDOC). The company's network of more than 3,100 members delivers on-demand healthcare to millions of patients via mobile devices, the Internet, video and phone. Teladoc members recently announced free consultations to victims of Hurricane Harvey, whether they were members of the service or not. The company said in a press release it would provide non-emergency medical care to those people displaced from their regular doctors and routines (http://nnw.fm/272lJ).
The idea that large healthcare organizations can offer real-time help through telemedicine is taking shape in other ways. Cigna (NYSE: CI), one of the nation's largest managed-care organizations with a little over 14 million medical members, recently reached out to victims of the mass shooting in Las Vegas, offering online support services for anyone affected by the tragedy in any way (https://www.cigna.com). Cigna typically provides health insurance services to individuals mainly through the group or employer market. Cigna is a leader in the commercial self-funded fee market and participates in other insurance and retirement businesses.
Prior to the approach of Hurricane Irma in September, Anthem (NYSE: ANTM) announced that it would also offer free online medical and psychological visits to anyone impacted by the natural disaster (http://nnw.fm/jikF8). With approximately 40 million members, Anthem is one of the largest managed-care organizations in the United States. The company provides health insurance services to more than 74 million people through its affiliated companies.
UnitedHealth Group (NYSE: UNH) provides health insurance services to about 46 million medical members. The company provides health insurance services to its members through products for every major insurance market and delivers back-office services to providers through its Optum segment. UnitedHealth Foundation supports telemedicine services through a variety of methods, including offering grants to community initiatives developing new healthcare technologies (http://nnw.fm/3yW13).
Telemedicine continues to be one of the fastest growing sectors in the overall healthcare market, with most employers either in the planning stage of offering the service or already providing it to employees. This type of healthcare delivers new options to patients via a virtual encounter with qualified medical professionals. Telemedicine allows patients to have a continuous conversation with their primary care physicians, keeping patients more satisfied, while enabling physicians to gain a greater share of healthcare revenue. Online consultations with specialty care physicians are another important benefit of the rise in telemedicine, as are what some may call "curbside" consults for patients living in extremely rural parts of the country, according to an article in Forbes (http://nnw.fm/j7fSN).
Reducing the cost of healthcare while simultaneously increasing the quality of care and improving access to health services for millions of people will take a unique, forward-thinking vision made possible by companies that are strategically forging ahead as telemedicine pioneers. Natural disasters aren't the only time when telemedicine is destined to shine. It is in the everyday, individual approach to helping people live better, healthier lives by connecting them with medical providers who want to take a more comprehensive, continuous role in patient care.
For more information on Medical Innovation Holdings, please visit: http://medicalinnovationholdings.com/
$PSID Check out on PST - http://www.pennystocktweets.com/stocks/profile/PSID
$PSID will be adding Drone Technology to their Specialty Vehicles
http://www.e-n-g.com/other-specialty
$MIHI recently announced the launch of their Spanish-Language Telemedicos USA. Telemedicos USA telemedicine platform provides 24/7 access to Spanish-speaking physicians and specialists, including discounts, medications, alternative medications, laboratory services, and risk shared health coverage programs.
Hispanics are the largest minority group in the country, and represent the majority of U.S. millennials. By connecting with this demographic, while also serving its older generations, MIHI is positioned to accommodate the needs of this group long term.
Additionally, the Hispanic population has a high incidence of diabetes and overweight individuals, revealing the long-term need for MIHI to establish itself as the leader in telemedicine-based programs for this group. Telemedicos USA provides the opportunity for MIHI to deliver its specialty services to a market of considerable size, and to those who prefer the Spanish language.
https://www.prnewswire.com/news-releases/medical-innovation-holdings-inc-mihi-launches-spanish-language-telemedicos-usa-650587583.html
AMFE! Super news!!
Uplist and Free Dividend Share Spinoff very soon after! Millions in revenue only growing and growing quarter after quarter!
So much incredible stuff!
Buy, Hold, Buy More, Hold
$$ $AMFE$$$$
New investors in Silicon Valley biotech (under .01/share) Arrayit Corporation (ARYC):
@Arrayit on Twitter
Please do your due diligence on this Silicon Valley biotech company and you will see what an extremely undervalued company this is. It is finally getting the attention it deserves
http://www.arrayit.com/
Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
The ARYC charts:
http://stockcharts.com/h-sc/ui?s=Aryc
A list of Arrayit Corporation patents:
https://t.co/EMXlE743rz
Here's a few recent updates from their website. For more links @ Arrayit and $ARYC on Twitter.
Please follow ARYC on Facebook for more updates
Arrayit microarray technology platform customers featured widely in Wells Fargo report by top analyst Tim Evans arrayit.com/confidential/l…
Arrayit advances OEM relationship with global medical technology and supply leaders GE Healthcare Chicago IL www3.gehealthcare.com/en
Arrayit featured with market leaders Illumina, Fluidigm and Affymetrix by world business insights leader Owler owler.com
Arrayit reports numerous emails to advance audit completion with top public company accounting firm RRBB Somerset NJ rrbb.com
Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $190,000 microarray services sale to a top research laboratory located in the Southern United States
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
?@arrayit?
Arrayit reports Parkinson's Disease Test PDx™ partnering opportunity with top physician in Molecular Medicine India
(link: http://nimhans.ac.in)
nimhans.ac.in
Arrayit reports $35,000 microarray services sale to a leading research laboratory specializing in complex pathways
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $168,000 microarray platform sale to leading medical suppliers Medi Laser located in Lahore Pakistan (link: http://www.medilaser.com.pk) medilaser.com.pk
Arrayit reports $100,000+ microarray services sale to a leading US-based research laboratory (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD
http://www.
defense.gov
Arrayit microarray platform used by customers at University Medicine Bethesda MD to publish cancer research advance
www.twitter.com/arrayit
Arrayit schedules business development meeting today with top Vietnamese biotech firm regarding $10MM+ potential microarray growth account.
Arrayit customers in Toronto Canada use Arrayit microarray technology to publish advance on heart transplantation
http://
journals.plos.org/plosone/articl
e?id=10.1371/journal.pone.0151224
…
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit reports record blood card sales in Q3-16 on microarray immunoassay research apps http://www.arrayit.com/Produc
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance
http://
onlinelibrary.wiley.com/doi/10.1111/xe
n.12260/full
…
Arrayit quotes $160,000 microarray platform to molecular diagnostic leader Akonni Biosystems http://www.akonni.com
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia
?http://www.?
?chembio.ru?
Arrayit reports $34,500 SpotBot 4 Microarray platform sale, leading European Distributor Grupo Taper Sintra Portugal http://www.arrayit.com/Products/Microarrayers/Microarrayer/microarrayer.html …
Arrayit reports microarray sale to testing leader RDL Reference Laboratory Los Angeles CA http://www.rdlinc.com
Arrayit ships $40,000 microarray platform life sciences leader Daemyung Sciences Seoul Korea http://www.dm4you.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance
http://www.
sciencedirect.com/science/articl
e/pii/S1873506115000598
…
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
?http://?
?fb.me/2Xx9b1Oom?
Arrayit reports $30,000 microarray services sale to a top research
Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España http://www.progenie-molecular.com
Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines http://www.dlsu.edu.ph
Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group http://www.leadingtechnology.co
Arrayit Corporation ?@arrayit
Arrayit completes conference call on huge DNA testing opportunity in massive market in India http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html …
Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html …
Arrayit Corporation ?@arrayit
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada http://www.uottawa.ca
Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan http://waki-bg.jp
Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA http://www.autogenomics.com
Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium http://www.euro-bio-net.com
Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA http://web.mit.edu
Arrayit expands marketing on $100K TissueMax™ Automated and Personal Tissue Microarrayers sale
***PKTX..Protokinetix's PR News Release
....ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) is pleased to provide a scientific update to its stockholders. The Company is exploring the following areas for the use of its AAGP™ family of molecules:
Presently at the University of Alberta:
1. Diabetes (study started February 2017)
The PKX-001 (AAGP™’s clinical name) Study is treating islet cells prior to transplantation into human test subjects. The clinical trials are assessing any side effects or physiological damage to the test subjects. The study is looking for indications of protection from tacrolimus toxicity and enhanced engraftment survival of the transplanted cells.
The clinical trials are well underway and will continue throughout the end of the year with enrollment of up to ten patients. To obtain additional information and updates regarding the trials please use the following link: Clinicaltrials.gov - Islet Transplantation Using PKX-001.
2. Kidney Ischemia (anticipated start date 4th quarter 2017)
Ischemia is a condition that occurs when blood flow to cells, tissues or organs is severely restricted. This condition can affect any part of the human body. When this circumstance transpires, cell death and organ damage follows very rapidly. Ischemia is a major cause of kidney damage, heart attacks and strokes.
Our testing is to determine whether AAGP™ can reduce the inflammatory response that causes cell damage and organ failure that occurs during an ischemic attack.
3. Normothermic Liver Perfusion (start date to be determined)
Normothermic (body temperature), ex vivo (outside the body) liver perfusion (method of irrigation) is an innovative therapy applied to donor livers outside of the body before transplantation that improves organ quality and makes organs that were previously unsuitable safe for transplant.
Our planned testing is to determine the beneficial effects of adding AAGP™ to the perfusate solution. Perfusate solutions are used to protect donor organs from the period of harvest until transplantation. We hope to evidence that AAGP™ can extend the viable life of harvested transplant organs.
Presently at the University of British Columbia:
1. Retinal Cell Replacement (started June 2016)
The research program at the University of British Columbia, under the guidance of Dr. Gregory-Evans will be determining whether AAGP™ can help improve the survival of stem cells that are currently being used in human trials to treat retinal blindness. We are doing this because of the poor outcome in the current state of play using stem cells in the treatment of blindness. Proof of principal work has been done in animal models but these successes are few and far between. What has been seen most recently is that probably as few as 10% of injected cells are surviving more than a week. Although this is adequate for proof of principle work, it is not good enough for developing a clinical medical treatment. We are looking for ways to improve cell survival in actual living eyes.
The study conducted by the Gregory-Evans Retinal Therapeutic Lab at the University of British Columbia compared the results of transplanted retinal precursor cells with and without the addition of AAGP™. The cells treated with AAGP™ showed a dramatic improvement on cell survivability and viability, functionality compared to the untreated cells. Ongoing testing is now being conducted to determine if these transplanted cells are fully functioning.
2. Monoclonal Antibody Production (anticipated start date 4th quarter 2017)
Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope. The use of monoclonal antibodies to treat diseases is called immunotherapy because each type of monoclonal antibody will target a specific targeted antigen in the body. Monoclonal antibodies are currently being used to treat Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Cardiovascular Disease, Systemic Lupus Erythematosus, Crohn's Disease, Ulcerative Colitis, Psoriasis, Transplant Rejection, and several more conditions.
By adding AAGP™ into the culture medium, we are hoping to show a substantial increase in viable monoclonal antibodies that could lead to a dramatic decrease in the cost of production of monoclonal antibody medicines.
We are working at initiating programs on:
1. Bone Marrow Recovery (preliminary stage)
Bone marrow is the flexible tissue in the interior of bones. In humans, red blood cells are produced by cores of bone marrow in the heads of long bones in a process known as hematopoiesis. It can be collected and cryopreserved. Conditions that can be treated by transplantation include bone marrow diseases, histiocytic disorders, hemoglobin opathies, inherited immune system disorders, inherited metabolic disorders, leukemias and lymphomas, myelodysplastic syndromes, multiple myeloma, plasma cell disorders, other cancers and malignant diseases.
We will be testing to prove the viability and functionality of cryopreserved bone marrow increases with the addition of AAGP™.
2. Cord Blood Preservation (preliminary stage)
Cord blood is the blood left in the umbilical cord and placenta immediately after a baby is born. It can be collected, stored and used at any time during a baby’s lifetime to treat a wide variety of diseases and medical conditions. Cord blood is currently being used to treat multiple forms of cancer, hematopoietic diseases, inborn errors of metabolism and immune system diseases.
We will be testing to prove the viability and functionality of cryopreserved cord blood cells increases with the addition of AAGP™.
3. Ischemic Stroke Repair (anticipated start 4th quarter 2017)
Ischemic Stroke is usually associated with severe disabilities, high recurrence rate and other poor outcomes. Currently, there are no long-term effective treatments for stroke. Cell therapies have been explored previously. However, the therapeutic outcomes are often limited by poor survival of transplanted cells, difficult delivery, uncontrolled cell differentiation, ineffective engraftment with host tissues and non-sustained delivery of growth factors.
We will be testing to demonstrate that the AAGP™ molecule suppresses the inflammatory attack caused by ischemic stroke thereby preventing any long term damage to the human body.
Proactive Immune Sciences is conducting research on:
1. Immune Cell Cryopreservation Recovery (started June 2017 - anticipated end date 4th quarter 2017)
Immune based interventions represent one of the fastest growing, most promising areas of personalized medicine. This is particularly true for cancer, which is largely a disease of immune failure. Therefore, there is a strong impetus for individuals to bank healthy immune cells at as early an age as possible, before these cells are compromised by infection, malignancy, or simply advanced immunological age. The ability to use immune cells provides an oncologist another major tool in their arsenal to fight cancer.
Results to date have been very encouraging. We are hoping to prove the functionality of cryopreserved immune cells increases with the addition of AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences.
“We are delighted that research continues to support a growing belief in the potential benefits of AAGP™ for an expanding spectrum of medical applications. Through our international partnerships and academic relationships, we continue to explore and participate in well-designed scientific studies in support of a fundamental understanding of how AAGP™ can benefit numerous medical conditions. We are encouraged by the growing clinical data to support the effectiveness of AAGP™. I look forward to updating our stockholders with additional results as they become available as well as releases that will give a better understanding as to why we are conducting the study.” - Clarence E. Smith, President and Chief Executive Officer.
$PSID PositiveID’s E-N-G Mobile Systems’ Announces Incorporation of Advanced Drone Technology https://finance.yahoo.com/news/positiveid-e-n-g-mobile-120000332.html
$PMCB Type 1 diabetics may have a functional cure PMCB
Type 1 diabetes is one of the most complicated diseases to treat and cure. Doctors have to treat patients’ inability to produce insulin by their own pancreas. Many cures have been tried, including doctors introducing cells into the body to help produce insulin, but the immune system destroys the alien cells, making it impossible for the cells to work within the body. Now, a patent has been approved in the US, which may turn out to be the functional cure that Type 1 diabetes needs. In this method, cells which deliver insulin to the body have been merged with advanced technology, which lets them hide from the destructive immune system for many years. There are other cures which are also proving to be quite effective. Read on to find out more:
Melligen cells – the functional cure for Type 1 diabetes
Scientists at UTS, Sydney have been successful in genetically engineering ‘Melligen’ cells which can effectively release insulin in the patient’s body and regulate blood sugar levels in the same manner that the naturally produced beta cells are supposed to. These Melligen cells are able to store, produce and release insulin as needed by the body for keeping blood sugar levels at normal levels.
In collaboration with a biotechnology company called PharmaCyte Biotech, scientists at UTS have developed a unique product called the ‘Cell-in-a-Box’, which encapsulates the Melligen cells and hides them from the body’s immune system. The combination has been patented. This new technology will help diabetics in a very significant manner by helping them in getting rid of the need to inject themselves with insulin every day. It also protects them from the conditions which accompany diabetes such as kidney failure, blindness and cardiovascular problems.
How Melligen works
The coating that Melligen is encapsulated in, allows it to hide in the pancreas, without the fear of being attacked by the immune system. The special box is composed of a cellulose structure which lets the molecules move easily in or out making it possible for Melligen cells to release insulin when the blood sugar levels are down.
The box can stay within the body for a minimum of two years at least, without causing any damage to the nearby tissues, which makes it a viable long-term treatment for Type 1 diabetics.
https://drprem.com/health/mri-scan-importance-procedures-and-technology-in-india
$PUFXF ~ PUF Ventures Acquires Natures Hemp Corp.
https://finance.yahoo.com/news/puf-ventures-completes-acquisition-natures-201500064.html
$ABVG - after hour news! Village Tea Company Re-Launches E-commerce Platform
MIHI interactive stock chart >> https://finance.yahoo.com/chart/MIHI?ltr=1#symbol=MIHI;range=1d
Medical Innovation Holdings, Inc. (MIHI) owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) to bring quality medical care to all areas of need, including rural and underdeveloped areas across the country. Through its wholly owned 3Point Care subsidiary, MIHI provides personalized high-tech telemedicine encounters pairing the company's virtual health specialty doctors and traditional primary doctors that utilize next-gen virtual health technologies to connect a patient with a multi-disciplinary specialty clinical health care practice. Through its other companies and partnerships, MIHI offers Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.
http://medicalinnovationholdings.com/
$GEVO Gevo is leading the way in developing and implementing renewable technology to produce bio-based chemical products and next-generation biofuels that augment or replace petrochemicals, with a focus on isobutanol as a platform molecule.M http://www.gevo.com/about/our-business-leading-the-way-with-isobutanol http://www.gevo.com/about/our-business-leading-the-way-with-isobutanol/
GLNNF .52+.06Glance Technologies Announces Definitive Agreement to Receive $1 Million in Licensing Fees for a Mobile Payment App Tailored for Asians in North America
GlobeNewswire•October 16, 2017Comment
VANCOUVER, British Columbia, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Glance Technologies Inc. (GET.CN) (GLNNF) (CSE:GET.WT) (GJT) ?is announcing that further to the letter of intent announced on April 26, 2017, it has now entered into a definitive agreement with Euro Asia Pay Holdings Inc. to license its existing mobile payment system to create an app tailored for residents, students and tourists in North America from Asia and Europe.
"I have watched the mobile payments industry grow and evolve in Asia, North America and globally. Of all my ventures, I'm most excited about this one. There is no question that mobile payments are the future, they are already dominant in China and it is only a matter of time until the rest of the world follows," says Morris Chen, Euro Asia Pay Holdings Director.
Glance Pay is positioned to provide payment services that are similar to the ones in China and Europe using its Glance Pay Anywhere technology, which allows users to initiate and send payments to merchants from any location.
Alipay, and WeChat Pay together hold a commanding 90% of the market in China, leaving Apple Pay struggling to make inroads. This creates an opportunity to provide the alternative for visitors and new residents from China in Canada and the US.
In 2016, China’s mobile payments industry hit USD$5.5 trillion, roughly 50 times the size of America’s $112 billion market, according to consulting firm iResearch. It is clear that the ability to pay through mobile applications has become commonplace for Chinese consumers. This trend is continuing to move beyond China to destinations, such as Canada and the US.
According to Kantar TNS, even in other regions such as Singapore, 57% of connected consumers have used mobile payment, with more than a quarter (27%) doing so on a weekly basis. Chat apps popular in Asia such as WeChat and LINE have developed native payment applications facilitating everything from taxi bookings to eCommerce sales. This has helped to establish mobile payment methods as habitual for Asian consumers. In the Asia Pacific region, over half (53%) of connected consumers using mobile apps for payment at point of sale, in comparison to 33% in North America and 35% in Europe.
Chinese visitors contribute over $1 billion annually to the Canadian economy, and Canada is ranked at the 7th most popular academic destination for Chinese students.
“Visitors and new residents from the Asia Pacific region are already accustomed to mobile payments, which are overtaking cash and credit cards abroad, and we believe the trend is set to accelerate in Canada and the US as well. We believe we are well positioned to serve this growing market,” says Desmond Griffin, CEO of Glance.
Under the terms of the agreement, Euro Asia Pay shall pay $1,000,000 to Glance Pay as follows:
$405,000 in cash for licensing with $250,000 payable on signing and $155,000 payable within 90 days; plus $210,000 payable by way of 3,000,000 shares of Euro Asia at a deemed price of $0.07 per share
$175,000 for design of the app with a unique user experience, $175,000 payable within 60 days through the issuance of 2,500,000 shares of Euro Asia at a deemed price of $0.07 per share
$210,000 within 60 days or marketing and advertising of the new app, payable through the issuance of 3,000,000 shares of Euro Asia at a deemed price of $0.07.
Glance has already received the first payment of $250,000 pursuant to the agreement. Immediately after the share issuances paid pursuant to the license agreement, Glance will own approximately 30% of Euro Asia Pay. Glance has agreed to enter into 3 year escrow provisions for the stock as set out in National Policy 46-201 Escrow for Initial Public Offerings.
This deal grants the Licensee a worldwide, non-exclusive license to use the Glance Pay mobile payments system in order to make, market and sell the new app.
This is the third licensing deal signed by Glance since May 2017, with a total of $3 million in deals signed in Fiscal 2017.
For more information about Glance, please go to Glance? ?Technologies'? ?website.
About Glance Technologies Inc.
Glance Technologies owns and operates Glance Pay, a streamlined payment system that revolutionizes how smartphone users choose where to dine, order goods and services, make payments, access digital receipts, redeem digital deals, earn great rewards & interact with merchants. Glance is building a valuable network of merchants and consumers, and offers targeted in-app marketing, geo targeted digital coupons, social media marketing, customer feedback, in-merchant messaging and custom rewards programs. The Glance Pay mobile payment system consists of proprietary technology, which includes user apps available for free downloads in IOS (Apple) and Android formats, merchant manager apps, a large scale technology hosting environment with sophisticated anti-fraud technology and lightning fast payment processing. Glance Pay has entered into significant licensing agreements to access the cannabis and fitness and wellness industries through Active Pay Distribution Inc. and Cannapay Financial Inc. Through its licensing strategy, Glance is diversifying its holdings by acquiring equity positions in emerging high growth companies.
For more information about Glance, please go to www.glance.tec
Headed for $Land
$HTBX Next stop $.88
$GEVO "Gevo has been producing and selling its patented alcohol-to-jet fuel (ATJ) derived from isobutanol since 2011. Gevo is working toward further commercializing its patented ATJ, which is a clean burning, homegrown, drop-in jet fuel that has the potential to deliver aviation biofuels at scale and at competitive cost. Fossil-based jet fuel is one of the largest expenses for airlines. Gevo?s ATJ is expected to help reduce the airline industry?s carbon footprint and help control fuel costs."
http://www.gevo.com/our-markets/jet-fuel/
TONR CC MondayOct.16 links number to ask your Questions
The conference call will begin at 1:00 PM central time on Monday, October 16th and will also feature a live question and answer chat room via the tonneroneworld.com website. The company will issue a statement via its twitter account at @oneworlddolls with a link to the chat room 30 minutes prior to the call. The number to call in will be 712-432-0075 pin 278621#.
http://tonneroneworld.com/
https://twitter.com/oneworlddolls
TODAY TONR Buy Earlier Before Conference Call Today!
http://investorshub.advfn.com/boards/board.aspx?board_id=26126
Closed Friday with bid.0004/3M ask.0005/25M
$MIHI recent news >> Medical Innovation Holdings, Inc. (MIHI) Launches Spanish-Language Telemedicos USA
Telemedicos USA telemedicine platform provides 24/7 access to Spanish-speaking physicians and specialists, including discounts, medications, alternative medications, laboratory services, and risk shared health coverage programs
DULUTH, Georgia, October 12, 2017 /PRNewswire/ --
Medical Innovation Holdings, Inc. (OTC: MIHI) today announces the launch of Telemedicos USA (http://www.TelemedicosUSA.com), a Spanish-language health care platform positioned to address the needs of the 58 million Hispanics in the United States.
Hispanics are the largest minority group in the country, and represent the majority of U.S. millennials. By connecting with this demographic, while also serving its older generations, MIHI is positioned to accommodate the needs of this group long term.
Additionally, the Hispanic population has a high incidence of diabetes and overweight individuals, revealing the long-term need for MIHI to establish itself as the leader in telemedicine-based programs for this group. Telemedicos USA provides the opportunity for MIHI to deliver its specialty services to a market of considerable size, and to those who prefer the Spanish language.
"This was a natural evolution for us. We purposefully positioned MIHI for this market because we understand the nuances of providing services to such an ethnically diverse group that make up the Hispanic community. We have a Mexican-American CEO, two of our three board members are Hispanic (Mexican American and Colombian), and some of our largest shareholders are Panamanian, Puerto Rican and Cuban. We know the Hispanic community, and the community knows us," stated MIHI CEO Jake Sanchez.
Telemedicos USA will use primary care, on-demand telemedicine services paired with 3PointCare's specialty network of doctors providing unparalleled access to health care. In addition, Telemedicos USA will offer pharmaceuticals, alternative medicines, and patient portals to create an electronic medical record (EMR) cloud-based that travels with the patient. With these features, Telemedicos USA can provide the nation's Hispanic population access to a doctor wherever they are.
About Medical Innovation Holdings, Inc.
Medical Innovation Holdings, Inc. (MIHI) owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) to bring quality medical care to all areas of need, including rural and underdeveloped areas across the country. Through its wholly owned 3Point Care subsidiary, MIHI provides personalized high-tech telemedicine encounters pairing the company's virtual health specialty doctors and traditional primary doctors that utilize next-gen virtual health technologies to connect a patient with a multi-disciplinary specialty clinical health care practice. Through its other companies and partnerships, MIHI offers Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.
We serve a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.
For more information, visit http://www.MedicalInnovationHoldings.com.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.
Investor Contacts:
Medical Innovation Holdings
Office: +1-866-883-3793
Investor@MedicalInnovationHoldings.com
Communications Contact:
NetworkNewsWire (NNW)
New York, New York
http://www.NetworkNewsWire.com
Office: +1-212-418-1217
Editor@NetworkNewsWire.com
SOUPQ IF YOU READ THIS AND CANT CONNECT THE DOTS ITS ON YOU
SOUPQ FACTUAL POSTS HAVE BEEN GETTING DELETED LEFT AND RIGHT FOR A MONTH NOW as asymmetric\nincompoopish bashing is allowed to reign supreme. WHAT ARE THEY SO SCARED OF THE FACTS FOR?. Its the only reason SOUPQ is this low right now. ONLY REASON. I just posted the TRADES AND THE ACTUAL PR BY THE NEW MANAGEMENT and it got deleted....READ THE TRADES NOT THE LIPS, THEY ARE NAKED SHORTING THIS BABY IMO. You have never been served something so lifechanging serbved to you as freely as all the information you have at your hands and ignore. ALL THE DOTS, THE 194 MILLION SHARES OWNED BY WEALTH COLONY AND CREW. JEFFEREY FRIEDMANS 66 MILLION SHARES BOUGHT IN THE OPEN MARKET WITH HIS OWN PERSONAL MONEY. SOUPQ CAN RUN TO $1, risk reward is HEAVILY UNBALANCED lever POINTING TOWARDS REWARD. REVERSE MERGER? Whatever it may be, i suspect that the 194 million shares will be used for something. Play stock detective for once in your life...FOLLOW THE TRAIL... THE BRAND is more important than the private entity. THE BRAND IS WHAT IS GOING TO MAKE WEALTH COLONY HUNDREDS OF MILLIONS... YES I SAID HUNDREDS. Did you even read the PR, THE BRAND THE BRAND THE BRAND THE BRAND
below is the post that got deleted? Why
SOUPQ NOTHING NEEDS TO BE SAID. I told you guys 2 days before the PR that I noticed MASSIVE BIDS and huge loading then BAM UP 700% IN 1 DAY WITH MASSIVE BLOCK BUYS, These sellouts on low volume do not represent the HUGE ACCUMULATION that has and is taking place. NOTICE THE 1.3 MILLION BID that got filled at .0255 yesterday? NOTICE THE 1.3 MILLION BID TODAY...The person or PEOPLE (WC friends and family) are not talking on IHUB. READ THE TRADES NOT THE LIPS. 194 MILLION shares is a good trigger for any smart trader. Keep saying "SHELL" even as a "shell" SOUPQ will not just be thrown away
HEDGEFUNDS LIKE MAKING MONEY, would you just throw 194 million shares away? Well if you are one of these SMART bashers you would...LMFAOOOO. COMICAL. Thanks for the cheapies. I'm still ADDINGGGGG.
$SOUPQ too easy, u see how TING sells R & how HUGE THE BUYS R? https://t.co/kyk067sCF6
$SOUPQ 2 easy u see how HUGE THE BUYS R? flippers like awe shucks. https://t.co/dWmcMpNZPV
Soupman, Inc. Emerges from Bankruptcy READ IT AGAIN ..WHOOOOOO EMERGES FROM BANKRUPTCY? WHO?
-Company's Brand & Financial Position Strengthen as New Management Completes Transition.
News provided by Gallant Brands, Inc. d/b/a Soupman, Inc.
NEWS PROVIDED BY
Gallant Brands, Inc.
Sep 28, 2017, 08:17 ET
EATONTOWN, N.J., Sept. 28, 2017 /PRNewswire/ -- Soupman, Inc. (the "company"), owner of the Original Soupman brand, emerged from bankruptcy on September 8, 2017, with a clean balance sheet and a new management team committed to living up to the brand's value.
The brand, created in 1984 by Al Yegenah and made famous by Seinfeld in 1995, filed for Chapter 11 bankruptcy protection on June 13, 2017, as a result of overbearing legacy liabilities and corporate governance issues.
After an arduous legal battle, Gallant Brands, Inc. ("GBI"), led by shareholders of the public entity (LED BY PEOPLE WHO STILL HAVE SHARES OF SOUPQ) acquired the assets of Soupman, Inc. from bankruptcy, eliminating over $11 million in debt and trade liabilities.
"We are selling great soup, and we're going to sell a lot more," said Joseph Hagan, president of GBI when asked if the business would continue operations. "A new regime is poised to finally capitalize on this brand's colossal value." (SOUP SUCH A LOVELY TICKER ISNT IT?)
Hagan continues:
"I am proud of the collective efforts of our team. We have all worked diligently to avoid interruption in operations and to identify those business opportunities that move our business forward. We are especially pleased to have the support of our long-term shareholders (Gallant Brands was created SPECIFICALLY TO BUY SOUPQ SO THEY DONT HAVE LONGTERM SHAREHOLDERS YET), vendors, suppliers, franchisees, and our customers. Their patience and commitment through this transitional period for Soupman has been pivotal in our re-emergence. We look forward to keeping the public informed of our streamlined business model, new customers, and exciting new opportunities."
About Gallant Brands, Inc.
Gallant Brands, Inc. (GBI) was founded with the specific purpose of purchasing Soupman, Inc. assets and operating the company under new management. GBI has identified one critical employee and has engaged a team of financial and food industry veterans with over 100 years' experience collectively as its management team. With an emphasis on strong cash flow, the Gallant team will implement simple operational changes, capable of saving the business over $1.2 million per year in spending while aggressively pursuing new business opportunities. Gallant is committed to communication, transparency, and accountability with the Soupman, Inc. constituents.
SOURCE Gallant Brands, Inc.
You just read:
Soupman, Inc. Emerges from Bankruptcy
NEWS PROVIDED BY
Gallant Brands, Inc.
Sep 28, 2017, 08:17 ET
http://www.prnewswire.com/news-releases/soupman-inc-emerges-from-bankruptcy-300527223.html
$PUFXF's Weed Points Loyalty is developing the first loyalty program that targets the emerging cannabis market by leveraging expertise and technology to create a platform that will allow producers, patients, and consumers to interact and define the future face of cannabis commerce. It is also developing WeedBeacon, a marijuana tracking technology. Learn more at: http://www.pufreport.com
$PSID Check out on PST - http://www.pennystocktweets.com/stocks/profile/PSID
$DATI aligns with leading accelerators and incubators to form unique partnerships that enhance the vetting process and expedite traction.
$DATI ~ What’s Going on with Cannabis & Equity Crowdfunding?
https://www.crowdfundinsider.com/2017/10/122604-whats-going-cannabis-equity-crowdfunding
$GFOO IN PLAY! NEVADA REINSTATEMENT, NEW CEO WITH HUGE PATENTS AND RUNS A $1.5 BILLION CO, and JUST HIRED A REVERSE MERGER ATTORNEY LAW FIRM.
Looks like they will have a Reverse Merger into what was previously an INACTIVE SHELL.
* They just Received "REINSTATEMENT" FROM NVSOS
* NEW CEO in AUGUST 2017
* HIRED NEW LAW FIRM THAT HANDLES REVERSE MERGERS
* CONFIRMED WITH ATTORNEY - TO WATCH FOR FILINGS AS THE COMPANY IS LOOKING TO BECOME CURRENT
http://deanlawcorp.com/home.html
http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=qDpp60ra6IvRyjUMURZhug%253d%253d&CorpName=GENUFOOD+ENERGY+ENZYMES+CORP.
https://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12216648
low float bitcoin GTRL 0003/5
Based in Henderson, Nevada – 1Bitcoin is owned and operated by Getting Real USA Corp.; a publically traded company stock symbol GTRL.
1bitcoin network is building a global savings, loyalty and rebate shopping platform exclusively for the crypto-currency Bitcoin..
http://1bitcoincorp.com/about-us/
$GTRL been hit hard, bitcoin $5300 now, bitcoin ticker, recently finished acquiring 1BitCoinCorp. pic.twitter.com/tpXauPhQnd
— PAPA SOLANA (@papaonsolana) October 12, 2017
CAN SOUPQ .0159 BECOME A $5 STOCK IN 2 YEARS? I THINK SO
GREAT POST BELOW
"SOUPQ .0159 I FEEL IT CAN BE A $10 STOCK IN 5 YEARS, HERES WHY
SOUPQ I feel we can trade above 50 cents in 6 months MAX. I remember AAAAMHIM alerted DEGH (ticker is now $DROP and after JV the original owners left the company and new owners diluted it to nothing pure shaddy diluting) at 0025 all the signs were there he told them about the JV hidden in the 8k NO ONE LISTENED, it ran from .0025 - $1.36 IN 6 MONTHS. Here in SOUPQ its not a tiny one sentence line hidden in an 8k. IT IS A HUGE 194 SHARE PURCHASE IN THE OPEN MARKET, A MASSIVE PR WHICH SCREAMS THE COLLOSAL VALUE OF THE BRAND BRAND BRAND. AN ASTONISHING TRACK RECORD OF TURN AROUND AND REVERSE MERGERS FOR Joe and Jeffery and people still snoozing.
IT IS TOO FUNNY THAT SLOW BASHERS ARE TRYING TO MAKE US BELIEVE THAT WC, Friedman, Hagan, all bought shares in an empty ticker; an empty shell of a company AND HAD NO PLAN AT ALL FOR THEIR SHARES AND ACTUALLY FEEL THAT THEY ARE SMART IN MAKING SUCH FOOLISHNESS? I really feel that i must be a genius among all those who believe in such NONSENSE. IT IS TOOOOOOOOOOOOOO COMICAL. Like sit back and THINK about this, I dont understand how you can listen to this without rolling on the floor laughing your butt off till you turn blue. Trust me i almost die with laughter when i read the posts of these bashers. STOP IGNORING THESE CHEAPIES ON SOUPQ FOLKS, this is not rocket science. JOE AND JEFFEREY ARE PROS, They are EXPERTSSSSSSSSSSS. This is far from their 1st rodeo. They do not read these boards they have bigger fish to fry. We are looking at a future $10+ stock in 5 years imo. Watch and see. SOUPQ
$SOUPQ 0162 u think WC BOUGHT 194 MILLION SHARES W/OUT A PLAN 4 THEM?💸🍾📽️💰 $GEQU $PFWI $ACRL $CDII $ARNH $ETST $APTY $AEPP $IFHR $BTFL $DCAC pic.twitter.com/xuWArIIwyI
— Obi (@aaaamhim) October 12, 2017
$DATI and #Equity partner #Fundanna featured in @crowdfundinside article #Cannabis #Crowdfunding https://finance.yahoo.com/news/digital-arts-media-network-music-144955637.html
$APH $GWPH $WEED
$EPAZ Epazz's other products are AgentPower™ (a workforce management software) and AutoHire™
$DATI will develop and acquire innovations that solve problems through digital platforms and other electronic applications.
WELCOME TRADERS!
Now let's work together and find The Next 5-10 Bagger!
10-bagger (n): A stock whose price multiplies 10 times over, leaving the shareholder euphoric, giddy, and ... rich.
Peter Lynch' Investment Philosophy:
His most famous investment principle is simply, "Invest in what you know," popularizing the economic concept of "local knowledge". This simple principle resonates well with average non-professional investors who don't have time to learn complicated quantitative stock measures or read lengthy financial reports. Since most people tend to become expert in certain fields, applying this basic "invest in what you know" principle helps individual investors find good undervalued stocks.
Lynch uses this principle as a starting point for investors. He has also often said that the individual investor is more capable of making money from stocks than a fund manager, because they are able to spot good investments in their day-to-day lives before Wall Street. Throughout his two classic investment primers, he has outlined many of the investments he found when not in his office - he found them when he was out with his family, driving around or making a purchase at the mall. Lynch believes the individual investor is able to do this, too.
He also coined the phrase "ten bagger" in a financial context. This refers to an investment which is worth ten times its original purchase price and comes from baseball where "bags" or "bases" that a runner reaches are the measure of the success of a play. A "two bagger" would be a double, so by extension, two home runs and a double would be a "ten bagger".
From: http://en.wikipedia.org/wiki/Peter_Lynch
http://huntforthenext10bagger.com/
Resources
This list was compiled originally by Brick. If you see this list on other boards, you can thank them for "borrowing" it.
1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany.jsp;jsessionid=00CD11F05D6090BBECE249167FD45A5B
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Please contact us to add any other Resources. We believe that every link above works. If you run across any that do not, please let us know.
Fifth Letter of Ticker Symbol Meanings:
A Class A.
B Class B.
C Exempt from Nasdaq® listing requirements for a limited period of time.
D A new issue of an existing stock. (Often the result of a reverse split.)
E Delinquent in required filings with the SEC as determined by the NASD®.
F Foreign.
G First Convertible Bond.
H Second Convertible Bond, same company.
I Third Convertible Bond, same company.
J Voting.
K Non-voting.
L Miscellaneous situations such as foreign preferred, preferred when-issued, a second class of units, a third class of warrants, or a sixth class of preferred stock.
M Fourth preferred, same company.
N Third preferred, same company.
O Second preferred, same company.
P First preferred.
Q In bankruptcy proceedings.
R Rights.
S Shares of beneficial interest.
T With warrants or with rights.
U Units.
V When-issued and when-distributed.
W Warrants.
X Mutual Fund.
Y ADR (American Depositary Receipts).
Z Miscellaneous situations such as a second class of warrants, a fifth class of preferred stock, a stub, a foreign preferred when-issued, or any unit, receipt, or certificate representing a limited partnership interest.
Absolutely too many to list!
Contact Section
Ruliquid:
WEBSITE http://huntforthenext10bagger.com/
IHUB: http://investorshub.advfn.com/boards/profilea.aspx?user=25547
Twitter: http://twitter.com/ruliquid
Email: ruliquid@gmail.com
Facebook: http://www.facebook.com/ruliquid.daytrader
For "SKYPE" users find me ruliquid.daytrader
Bragging Rights:
DISCLAIMER:
Opinions expressed on this board are just that. Opinions. We are not licensed brokers. Trading strategies discussed on this board are often high risk and not suitable everyone. If you are losing money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU. If you follow stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY. Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do your own due diligence before buying or selling ANY SECURITY in the open market, there are no guarantees.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |